ORGO
Organogenesis Holdings Inc
1.40$
-2.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 27.8% | 30.3% | 0.5% | 0.1% | 43.5% | 56.9% | 60.1% | 51.2% | 49.5% | 48.9% | 57.4% | 60.5% | |
| 7.6% | 30.3% | 0.3% | 0.0% | 13.0% | 27.3% | 29.1% | 25.7% | 22.8% | 22.7% | 27.2% | 15.6% | |
| – | 30.3% | 0.3% | 0.0% | 13.0% | 27.3% | 29.1% | 25.7% | 22.8% | 22.7% | 27.2% | 15.6% | |
| 5.9% | – | 6.1% | 9.0% | 20.8% | 17.8% | 19.6% | 18.6% | 19.9% | 17.8% | 22.1% | 36.3% | |
| 7.8% | – | 4.3% | 4.6% | 8.1% | 10.4% | 9.6% | 5.6% | 5.5% | 6.1% | 5.3% | 4.9% | |
| 70.4% | – | 14.6% | 13.5% | 24.2% | 21.4% | 20.7% | 17.9% | 22.8% | – | – | – | |
| 0.0% | – | 2.0% | 8.2% | 15.6% | 11.6% | 9.9% | 6.5% | 6.4% | 6.3% | 5.8% | 4.8% | |
| 0.0% | – | 3.7% | 9.5% | 15.9% | 9.4% | 10.6% | 5.8% | 4.6% | 3.5% | 2.5% | 1.5% | |
| 179.5% | 100.0% | 3.6% | 4.7% | 71.3% | 74.8% | 51.1% | 45.6% | 40.9% | 39.4% | 22.6% | 27.5% | |
| 37.0% | 100.0% | 0.2% | 1.3% | 40.6% | 27.1% | 23.5% | 18.7% | 16.7% | 17.5% | 15.6% | 16.7% | |
| 0.0% | 42.0% | 0.0% | 1.7% | 2.9% | 1.4% | 7.0% | 3.3% | 3.6% | 4.3% | 1.8% | 3.1% | |
| 18.4% | – | 3.8% | 6.1% | 11.7% | 12.9% | 8.1% | 6.6% | 7.2% | 6.7% | 5.8% | 5.3% | |
| 95.8% | – | 23.6% | 28.5% | 23.9% | 37.7% | 18.3% | 16.0% | 14.7% | 13.2% | – | – | |
| -79.5% | 0.0% | 96.4% | 95.3% | 28.7% | 25.2% | 48.9% | 54.4% | 59.1% | 60.6% | 77.4% | 72.5% | |
| -687.1% | -6.0% | -0.1% | -0.7% | -79.6% | -77.5% | -53.4% | -13.7% | -10.1% | -8.9% | -8.1% | -0.5% | |
| – | 15,134.4% | 2.8% | 20.4% | 42.4% | 42.1% | 38.4% | 30.2% | 29.5% | 28.9% | 26.4% | 21.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.